Kill power of oral antifungals against dermatophytes

Pediatric Infectious Disease Journal

Volumn 18, Issue 2, 1999, Pages 200-204

  Hazen, Kevin C ^a   Wu, Giangqin ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Amphotericin B.; Dermatophytes; Fluconazole; Griseofulvin; Itraconazole; Microsporum; Terbinafine; Trichophyton

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

CONFERENCE PAPER; DERMATOMYCOSIS; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PREDICTION; PRIORITY JOURNAL;

EID: 0032990956     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199902000-00028     Document Type: Conference Paper

References (6)

1. Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J Am Acad Dermatol 1998;38:S37-41.
2. Espinel-Ingroff A, Barchiesi F, Hazen KC, Martinez-Saurez JV, Scalise G. Standardization of antifungal susceptibility testing and clinical relevance. Med Mycol 1998;36(Suppl. 1):68-78.
3. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994;19:121-6.
4. Schatz F, Bräutigam M, Dobrowolski E, et al. Nail incorporation kinetics of terbinafine in onychomycosis patients. Clin Exp Dermatol 1995;20:377-83.
5. Faergemann J. Pharmacokinetics of terbinafine. Rev Contemp Pharmacother 1997;8:289-97.
6. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol 1993;18:102-6.